Physician

Bachar Dergham, MD

According to 2025 Medicare claims, Bachar Dergham, MD (NPI: 1013016930) practices medical oncology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44131-2172. Dergham is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Dergham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 293 traditional Medicare patients, billed 641 HCPCS/CPT codes, and received $37,388 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,045 prescription claims across 213 beneficiaries totaling $4,072,374 in drug costs, led by Revlimid (Lenalidomide). DME data shows 42 claims. Open Payments data shows 52 records totaling $72,008. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $57,957 to $37,388. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $781,507 to $4,072,374. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $2,739 to $330.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$64K$128K2015 Medicare payment: $57,957 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $108,074 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $104,476 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $127,781 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $80,606 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $35,715 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $38,393 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $40,853 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $43,569 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $37,388 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153901,060$57,957
20164301,485$108,074
20174251,390$104,476
20184201,500$127,781
20193721,111$80,606
2020327726$35,715
2021281624$38,393
2022295659$40,853
2023314731$43,569
2024293641$37,388

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$4.1M2015 Drug cost: $781,507 (USD; Tot_Drug_Cst)2016 Drug cost: $1,569,449 (USD; Tot_Drug_Cst)2017 Drug cost: $1,553,567 (USD; Tot_Drug_Cst)2018 Drug cost: $2,086,448 (USD; Tot_Drug_Cst)2019 Drug cost: $2,124,822 (USD; Tot_Drug_Cst)2020 Drug cost: $2,888,452 (USD; Tot_Drug_Cst)2021 Drug cost: $3,233,670 (USD; Tot_Drug_Cst)2022 Drug cost: $3,226,262 (USD; Tot_Drug_Cst)2023 Drug cost: $3,689,844 (USD; Tot_Drug_Cst)2024 Drug cost: $4,072,374 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015166700$781,507
2016192935$1,569,449
20172041,006$1,553,567
20182071,061$2,086,448
20192111,215$2,124,822
20201911,145$2,888,452
20211951,046$3,233,670
20222021,039$3,226,262
20232201,111$3,689,844
20242131,045$4,072,374

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$33K$66K2015 Medicare payment: $65,803 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $53,051 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $10,297 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $19,512 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,441 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,984 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,014 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $6,833 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,229 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R93$65,803
2016N/R136$53,051
2017N/R34$10,297
201826120$19,512
2019N/R48$4,441
2020N/R72$3,984
2021N/R29$1,014
2022N/RN/RN/R
2023N/R50$6,833
2024N/R42$1,229

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2424$101
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2324$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more115191$67
99443Telephone medical discussion with physician, 21-30 minutes2530$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more186328$43

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide381,064$767,875
LenalidomideLenalidomide571,596$746,893
IbrancePalbociclib361,008$553,327
PomalystPomalidomide21588$470,295
JakafiRuxolitinib Phosphate25730$415,272

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R21$833
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R21$395

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.52$72,008BeiGene USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Bachar Dergham, MD?

Tedicare shows public-source Medicare data for Bachar Dergham, MD (NPI 1013016930), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bachar Dergham, MD have ACO affiliation data?

Bachar Dergham, MD is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Bachar Dergham, MD?

Bachar Dergham, MD is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Bachar Dergham, MD have Open Payments data?

Bachar Dergham, MD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.